1062. Analysis of Resistance to Oral Standard of Care Antibiotics for Urinary Tract Infections Caused By Escherichia coli and Staphylococcus saprophyticus Collected Worldwide between 2019-2020

BACKGROUND: Gepotidacin (GSK2140944) is a novel triazaacenaphthylene bacterial type II topoisomerase inhibitor under development for the treatment of gonorrhea and uncomplicated urinary tract infections (UTI). This study reports on the in vitro activity of gepotidacin and other oral antibiotics when...

Descripción completa

Detalles Bibliográficos
Autores principales: Arends, S J Ryan, Butler, Deborah, Scangarella-Oman, Nicole, Paustian, Lindsey, Streit, Jennifer M, Mendes, Rodrigo E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644303/
http://dx.doi.org/10.1093/ofid/ofab466.1256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644303/
http://dx.doi.org/10.1093/ofid/ofab466.1256

Ejemplares similares